Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice

Reduced serotonin transporter (5-HTT) expression is associated with abnormal affective and anxiety-like symptoms in humans and rodents, but the mechanism of this effect is unknown. Transient inhibition of 5-HTT during early development with fluoxetine, a commonly used serotonin selective reuptake inhibitor, produced abnormal emotional behaviors in adult mice. This effect mimicked the behavioral phenotype of mice genetically deficient in 5-HTT expression. These findings indicate a critical role of serotonin in the maturation of brain systems that modulate emotional function in the adult and suggest a developmental mechanism to explain how low-expressing 5-HTT promoter alleles increase vulnerability to psychiatric disorders.

[1]  D. Tayloe,et al.  Pediatrics , 1927, The Indian Medical Gazette.

[2]  J. Dudgeon.  Teratology. , 1986, Clinics of Perinatology.

[3]  J. Lauder,et al.  Serotonin as a differentiation signal in early neurogenesis. , 1978, Developmental neuroscience.

[4]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[5]  G. Vogel,et al.  A new animal model of endogenous depression: A summary of present findings , 1990, Neuroscience & Biobehavioral Reviews.

[6]  R. Summers,et al.  Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. , 1990, The Journal of pharmacology and experimental therapeutics.

[7]  J. Lauder,et al.  Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. , 1992, Teratology.

[8]  AC Tose.  Cell , 1993, Cell.

[9]  J. Lauder,et al.  Serotonin and cardiac morphogenesis in the mouse embryo. , 1993, Teratology.

[10]  M. Meaney,et al.  Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. , 1994, Brain research. Developmental brain research.

[11]  A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. , 1994 .

[12]  J. Lauder,et al.  Serotonin regulates mouse cranial neural crest migration. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Murray,et al.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. , 1996, Molecular psychiatry.

[14]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[15]  Streichenwein Sm,et al.  Am J Psychiatry , 1996 .

[16]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[17]  G. Vogel,et al.  Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression , 1997, Brain Research.

[18]  Shakti Sharma,et al.  Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. , 1997, Science.

[19]  P. Gaspar,et al.  Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: Determination of a sensitive developmental period , 1998, The Journal of comparative neurology.

[20]  B. Gutiérrez,et al.  Variability in the serotonin transporter gene and increased risk for major depression with melancholia , 1998, Human Genetics.

[21]  E. Frank,et al.  Pharmacologic treatment of depression during pregnancy. , 1999, JAMA.

[22]  J. Ashby.  References and Notes , 1999 .

[23]  J. Kent.  SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression , 2000, The Lancet.

[24]  D. Murphy,et al.  Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. , 2001, The Journal of pharmacology and experimental therapeutics.

[25]  Dennis L. Murphy,et al.  Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.

[26]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[27]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[28]  P. Gaspar,et al.  Lack of 5-HT1B receptor and of serotonin transporter have different effects on the segregation of retinal axons in the lateral geniculate nucleus compared to the superior colliculus , 2002, Neuroscience.

[29]  K. Perry,et al.  R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study , 2002, Neuropsychopharmacology.

[30]  D. Stewart,et al.  Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. , 2002, The American journal of psychiatry.

[31]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[32]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[33]  V. Arango,et al.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.

[34]  P. Gaspar,et al.  The developmental role of serotonin: news from mouse molecular genetics , 2003, Nature Reviews Neuroscience.

[35]  D. Murphy,et al.  Abnormal anxiety‐related behavior in serotonin transporter null mutant mice: the influence of genetic background , 2003, Genes, brain, and behavior.

[36]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[37]  M. Meaney,et al.  Variations in Maternal Care Alter GABAA Receptor Subunit Expression in Brain Regions Associated with Fear , 2003, Neuropsychopharmacology.

[38]  M. Ansorge,et al.  New Lessons From Knockout Mice: The Role of Serotonin During Development and Its Possible Contribution to the Origins of Neuropsychiatric Disorders , 2003, CNS Spectrums.

[39]  P. S. Zeskind,et al.  Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. , 2004, Pediatrics.

[40]  K. Lesch,et al.  Adaption of the serotoninergic neuronal phenotype in the absence of 5‐HT autoreceptors or the 5‐HT transporter: involvement of BDNF and cAMP , 2004, The European journal of neuroscience.

[41]  M. Meaney,et al.  A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety , 2004, Psychopharmacology.

[42]  Rene Hen,et al.  The developmental origins of anxiety , 2004, Nature Reviews Neuroscience.